| Fullerton Eyes Optometry | |
|
1319 S Harbor Blvd, Fullerton, CA 92832-3001 | |
| (714) 525-3330 | |
| (714) 525-3334 |
| Full Name | Fullerton Eyes Optometry |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1319 S Harbor Blvd, Fullerton, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063518181 | NPI | - | NPPES |
| GSD005590 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 11663T (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Fullerton Eyes Optometry 1319 S Harbor Blvd, Fullerton, CA 92832-3001 Ph: (714) 525-3330 | Fullerton Eyes Optometry 1319 S Harbor Blvd, Fullerton, CA 92832-3001 Ph: (714) 525-3330 |
News Archive
A Nature Biotechnology article published online January 17 reveals that Xencor Inc.'s proprietary Fc engineering extends the half-life of antibodies while maintaining their potency and extending duration of action. These results, published in an article entitled, "Enhanced antibody half-life improves in vivo activity" demonstrate the potential of Fc engineering to impact the flexibility of route, schedule and dose for nearly any antibody.
Akorn, Inc., a niche generic pharmaceutical company, today announced that its wholly-owned subsidiary, Oak Pharmaceuticals, has acquired three off-patent, branded, hospital-based injectables from the US subsidiary of H. Lundbeck A/S.
The first call in early April was from the testing center, informing the nurse she was positive for COVID-19 and should quarantine for two weeks.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that preclinical data related to CUDC-305, the company's Heat Shock Protein (HSP) 90 inhibitor, was published online this week in Molecular Cancer Therapeutics.
Researchers in the U.S. have shown that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may alter key protein structures on red blood cells and compromise the transport and delivery of oxygen in patients with coronavirus disease 2019 (COVID-19).
› Verified 9 days ago
Dr. Lisa M Harrison, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2575 Yorba Linda Blvd, Fullerton, CA 92831 Phone: 714-449-7428 Fax: 714-992-7871 | |
Dr. Regina Seen Won Garriott, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2575 Yorba Linda Blvd, Fullerton, CA 92831 Phone: 714-992-7870 Fax: 714-992-7871 | |
Dr. Carmen Nadine Barnhardt, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2575 Yorba Linda Blvd, Fullerton, CA 92631 Phone: 714-449-7423 Fax: 714-992-7871 | |
California Eye And Ear Specialists Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2240 N Harbor Blvd, 210, Fullerton, CA 92835 Phone: 714-278-1834 Fax: 714-278-1839 | |
Amy A Lytle, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2575 Yorba Linda Blvd, Fullerton, CA 92831 Phone: 714-449-7401 Fax: 717-992-7850 | |
Dr. Alan Sasai, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2575 Yorba Linda Blvd, Fullerton, CA 92831 Phone: 714-449-7496 Fax: 714-992-7871 |